Finance

Lists
Why is ALDX up 2.17%?
Dive Deeper
ALDX:NASDAQ
Aldeyra Therapeutics Inc
$0.64
+2.17%
(+0.014) 1D
$0.69
+7.18% (+0.046)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALDX...
Open
$0.61
High
$0.66
Low
$0.59
Mkt. cap
38.86M
Avg. vol.
1.46M
Volume
764.02K
52-wk high
$5.93
52-wk low
$0.53
EPS
-$0.32
Beta
1.32
Shares outstanding
60.36M
No. of employees
6
Open
$0.61
High
$0.66
Low
$0.59
Mkt. cap
38.86M
Avg. vol.
1.46M
Volume
764.02K
52-wk high
$5.93
52-wk low
$0.53
EPS
-$0.32
Beta
1.32
Shares outstanding
60.36M
No. of employees
6
News stories
From web sources and news partners
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees6
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to ALDX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ALDX in the last 3 months
Highest
Current $0.64
$2.00 (+210.66%)
Average
$2.00 (+210.66%)
Lowest
$2.00 (+210.66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Hold
Reiterated
$2.00
+210.7%
11/10/2026
Thomas Shrader
BTIG
Buy
Maintained
$9.00
+1,297.9%
03/17/2026
Clara Dong
Jefferies
Buy
Maintained
$7.00
+987.3%
10/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.30M
2.41M
3.48M
1.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.36M
1.14M
2.37M
2.30M
Operating expense
6.67M
3.55M
5.85M
4.14M
Total operating expenses
6.67M
3.55M
5.85M
4.14M
Operating income
-6.67M
-3.55M
-5.85M
-4.14M
Other non operating income
-
-
-
-
EBT including unusual items
-6.46M
-3.45M
-5.45M
-3.76M
EBT excluding unusual items
-6.46M
-3.45M
-5.45M
-3.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.46M
-3.45M
-5.45M
-3.76M
Net profit margin
-
-
-
-
Earnings per share
-0.10
-0.06
-0.09
-0.06
Interest and investment income
681.64K
562.98K
400.26K
373.75K
Interest expense
-475.26K
-468.68K
-23.00
-438.00
Net interest expenses
206.38K
94.30K
400.23K
373.31K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.60M
-3.48M
-5.78M
-3.98M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps